Daily Postoperative Complete Blood Counts After Primary Total Joint Arthroplasty May Not Always Be Necessary.

As the incidence of primary total hip and knee arthroplasties increases and reimbursement models shift toward a more quality-based model, orthopedic surgeons must focus on maintaining quality while containing costs. With current blood conservation strategies, serial laboratory testing after total joint arthroplasty (TJA) may not always be necessary. This study investigated the need for routine postoperative complete blood counts (CBCs) by determining preoperative and postoperative day 1 hemoglobin values that predict the need for a postoperative blood transfusion. Data were used to estimate potential cost savings. The medical records of all patients who underwent primary unilateral TJA performed by a single surgeon between October 2014 and September 2017 were reviewed. Patient demographic and procedural data were recorded, and statistical and cost analyses were performed. Of 108 TJAs, 9 (8.3%) patients received a blood transfusion during their postoperative inpatient stay. A preoperative hemoglobin value of 12.5 g/dL or less and a postoperative day 1 hemoglobin value of 10 g/dL or less were strong predictors of meeting the threshold transfusion trigger for a postoperative blood transfusion (area under the curve, 0.845 and 0.943, respectively). A 56% cost reduction ($845) could have been achieved by eliminating CBCs performed after postoperative day 1 in patients at low risk for transfusion. Patients with preoperative hemoglobin value levels greater than 12.5 g/dL and postoperative day 1 hemoglobin value levels greater than 10 g/dL may not require routine serial CBC monitoring after primary TJA. The cost savings in a high-volume joint center could be significant. [Orthopedics. 2020; 43(1): e31-e36.]. Copyright 2019, SLACK Incorporated.